phenytoin and dapsone

phenytoin has been researched along with dapsone in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19905 (25.00)18.7374
1990's2 (10.00)18.2507
2000's3 (15.00)29.6817
2010's10 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andricopulo, AD; Moda, TL; Montanari, CA1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Affrime, M; Reidenberg, MM2
Braun-Falco, O; Krieg, T; Schurig, V1
Reidenberg, MM1
Gibaldi, M1
Flores-Murrieta, FJ; Garcia-Arenas, G; Rios, C1
Chosidow, O; Cribier, B1
Chen, YC; Chiu, HC; Chu, CY1
Brandão, MAF; Ferreira, AO; Patrício, FB; Polonini, HC; Raposo, NRB; Silva, SL1

Reviews

4 review(s) available for phenytoin and dapsone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Effect of disease states on plasma protein binding of drugs.
    The Medical clinics of North America, 1974, Volume: 58, Issue:5

    Topics: Blood Proteins; Blood Urea Nitrogen; Creatinine; Dapsone; Digitoxin; Drug Interactions; Humans; Hypoproteinemia; Liver Cirrhosis; Methadone; Pharmaceutical Preparations; Phenytoin; Protein Binding; Quinidine; Serum Albumin; Triamterene; Uremia

1974
Pharmacokinetic aspects of drug metabolism.
    Annals of the New York Academy of Sciences, 1971, Jul-06, Volume: 179

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Azo Compounds; Dapsone; Dogs; Drug Therapy; Half-Life; Humans; Imidazoles; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Kinetics; Liver; Mathematics; Models, Biological; Pharmaceutical Preparations; Pharmacology; Phenytoin; Propranolol; Salicylates; Time Factors

1971
[Lichen].
    Annales de dermatologie et de venereologie, 1997, Volume: 124, Issue:1

    Topics: Adrenal Cortex Hormones; Cyclosporine; Dapsone; Griseofulvin; Humans; Immunosuppressive Agents; Lichen Planus; Metronidazole; Phenytoin; PUVA Therapy; Retinoids

1997

Other Studies

16 other study(ies) available for phenytoin and dapsone

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
The protein binding of some drugs in plasma from patients with alcoholic liver disease.
    European journal of clinical pharmacology, 1975, Apr-04, Volume: 8, Issue:3-4

    Topics: Alcoholism; Blood Proteins; Chronic Disease; Dapsone; Fluoresceins; Humans; Liver Diseases; Pharmaceutical Preparations; Phenytoin; Protein Binding; Quinidine; Triamterene

1975
[Hereditary bullous epidermolyses. Recent aspects of diagnosis and therapy].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1986, Volume: 37, Issue:4

    Topics: Antibodies, Monoclonal; Antibody Specificity; Autoantigens; Basement Membrane; Carrier Proteins; Chromosome Aberrations; Chromosome Disorders; Collagen; Collagen Type XVII; Cytoskeletal Proteins; Dapsone; Dystonin; Epidermolysis Bullosa; Fluorescent Antibody Technique; Genes, Recessive; Humans; Laminin; Microbial Collagenase; Nerve Tissue Proteins; Non-Fibrillar Collagens; Phenytoin

1986
Influence of disease on binding of drugs to plasma proteins.
    Annals of the New York Academy of Sciences, 1973, Nov-26, Volume: 226

    Topics: Arrhythmias, Cardiac; Arteriosclerosis; Blood Proteins; Blood Urea Nitrogen; Carbon Radioisotopes; Creatinine; Dapsone; Desipramine; Dialysis; Fluoresceins; Heart Failure; Humans; Hypoproteinemia; Liver Cirrhosis; Male; Methadone; Pharmaceutical Preparations; Phenytoin; Protein Binding; Quinidine; Triamterene; Ultrafiltration; Uremia

1973
Anticonvulsive effect of dapsone: interaction with phenytoin in the kainic acid model of seizures.
    Proceedings of the Western Pharmacology Society, 1997, Volume: 40

    Topics: Administration, Oral; Animals; Anticonvulsants; Dapsone; Drug Interactions; Injections, Intravenous; Kainic Acid; Phenytoin; Rats; Seizures

1997
Cutaneous drug reaction case reports: from the world literature.
    American journal of clinical dermatology, 2002, Volume: 3, Issue:1

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Bupropion; Celecoxib; Chlorquinaldol; Cytarabine; Dalteparin; Dapsone; Dermatitis, Contact; Drug Hypersensitivity; Felodipine; Female; Humans; Male; Middle Aged; Phenytoin; Pregnancy; Pyrazoles; Scabies; Sulfonamides; Sweet Syndrome; Vancomycin

2002
Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases.
    Archives of dermatology, 2010, Volume: 146, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Anti-Infective Agents; Anticonvulsants; Child; Dapsone; Drug Eruptions; Eosinophilia; Female; Gout Suppressants; Humans; Male; Middle Aged; Pancytopenia; Phenytoin; Prognosis; Retrospective Studies; Risk Factors; Taiwan; Young Adult

2010
Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend(®) SF PH4 oral suspensions.
    Journal of pharmaceutical and biomedical analysis, 2016, Jan-25, Volume: 118

    Topics: Administration, Oral; Amlodipine; Chloroquine; Chromatography, High Pressure Liquid; Dapsone; Drug Stability; Drug Storage; Feasibility Studies; Hydrogen-Ion Concentration; Isoxazoles; Phenytoin; Pyridoxine; Sulfadiazine; Sulfasalazine; Suspensions; Tetracycline; Trimethoprim; Zonisamide

2016